SCPX — Scorpius Holdings Share News
0.000.00%
Last trade - 00:00- $0.01m
- $11.13m
- $6.24m
Brief: Heat Biologics Inc Files For Offering Of 22.6 Million Shares Of Common Stock, Common Warrants To Purchase 11.3 Million Shares Of Common Stock
Brief: Heat Biologics Files For Offering Up To 38.4 Mln Shares Of Common Stock
Brief: Heat Biologics Files For Common Stock Offering Of Up To $17.25 Mln
Brief: Heat Biologics Posts Quarterly Loss Per Share Of $0.14
Brief: Heat Biologics Inc Received Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
Brief: Heat Biologics Says Has No Current Plans To Raise Funds Through Sales Under Its At Market Issuance Sales Facility Or Conduct A Financing
Brief: Heat Biologics Provides Data From Phase 2 Study Investigating Hs-110 In Combination With BMY's Nivolumab
Brief: Heat Biologics Reports Qtrly Loss Per Share of $0.17
Brief: Heat Biologics Inc - On Track To Complete Enrollment Of Phase 2 Lung Cancer Trial In Q2 2019 And Report Additional Interim Data In Q4 2019
U.S. STOCKS ON THE MOVE-Tesla, Boeing, Facebook, Shopify, Micron, Office Depot
U.S. STOCKS ON THE MOVE-Boeing, Tesla, Facebook, Constellation Brands, Office Depot
U.S. STOCKS ON THE MOVE-Boeing, Tesla, Facebook, Office Depot
U.S. STOCKS ON THE MOVE-Tesla, Facebook, Micron, Roku, Office Depot
Heat Biologics: Falls on plans to raise $18 mln in equity
Brief: Heat Biologics Says Entered At Market Issuance Sales Agreement
U.S. STOCKS ON THE MOVE-PVH Corp, Accenture, Nielsen Holdings, Verizon Communications, Lululemon Athletica
U.S. STOCKS ON THE MOVE-PVH Corp, Accenture, Nielsen Holdings, Verizon
Heat Biologics: Rises after update on lung cancer drug trial
Brief: Heat Biologics Says On Track To Complete Enrollment Of Phase 2 Lung Cancer Trial In Q2 2019